BRCA1 and BRCA2 genes mutation analysis in patients with a family history of breast and ovarian cancer

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 3, 2004, Pages 271-277

  Konstantopoulou, Irene ^a   Janković, Radmila ^b   Raičević, Lidija ^b   Ladopoulou, Angela ^a   Armaou, Sophia ^a   Nikolopoulos, George ^a   Pandis, Nikos ^c   Nasioulas, George ^d   Radulović, Siniša ^b   Yannoukakos, Drakoulis ^a  

^a Demokritos Natl Ctr of Sci Res   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c Saint Savvas Anticancer Hospital   (Serbia)

^d HYGEIA Molecular Biology Dept   (Serbia)

Author keywords

BRCA1; BRCA2; Breast ovarian cancer; Familial; Greece; Serbia

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; GENOMIC DNA;

BREAST CANCER; CONFERENCE PAPER; DNA SEQUENCE; FAMILY HISTORY; GENE MUTATION; GREECE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PEDIGREE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; YUGOSLAVIA;

EID: 4644337856     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0403271K     Document Type: Conference Paper

References (22)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Canon-Allbright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
2. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-2.
3. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
4. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997; 60: 1013-20.
5. Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, Proc Natl Acad Sci USA 2000; 97: 9603-8.
6. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer, Cancer 1996; 77: 2318-24.
7. Neuhausen SL. Ethnic differences in cancer risk resulting from genetic variation. Cancer 1999; 86: 2575-82.
8. Hodgson SV, Haites NE, Caligo M, Chang-Claude J, Eccles D, Evans G, Moller P, Morrison P, Steel CM, Stoppa-Lyonnet D, Vasen H. A survey of the current clinical facilities for the management of familial cancer in Europe. European Union BIOMED II Demonstration Project: Familial Breast Cancer: audit of a new development in medical practice in European centres. J Med Genet 2000; 37: 605-7.
9. Santarosa M, Dolcetti R, Magri MD, Crivellari D, Tibiletti MG, Gallo A, Tumolo S, Della Puppa L, Furlan D, Boiocchi M, Viel A. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy. Int J Cancer 1999; 83: 5-9.
10. Papp J, Raičević L, Milasin J, Dimitrijević B, Radulović S, Olah E. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families. Oncol Rep 1999; 6: 1435-8.
11. Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 2000;83:737-42.
12. Konstantopoulou I, Kroupis C, Ladopoulou A, Pantazidis A, Boumba D, Lianidou ES, Petersen MB, Florentin L, Chiotellis E, Nounesis G, Efstathiou E, Skarlos D, Tsionou C, Fountzilas G, Yannoukakos D. BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Hum Mutat 2000; 6: 272-3.
13. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999; 49: 138-144.
14. Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, Armaou S, Tsiagas I, Lianidou ES, Efstathiou E, Tsionou C, Panopoulos, Mihalatos M, Nasioulas G, Skarlos D, Haites NE, Fountzilas G, Pandis N, Yannoukakos D. Germline BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett 2002; 185: 61-70.
15. Ladopoulou A, Konstantopoulou I, Armaou S, Efstathiou E, Mihalatos M, Nasioulas G, Bardi G, Pandis N, Yannoukakos D. A change in the last base of BRCA1 exon 23, 5586G>A, results in abnormal RNA splicing. Cancer Genet Cytogenet 2002; 134: 175-7.
16. Hayes F, Cayanan C, Barilla D, Monteiro AN. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation. Cancer Res 2000; 60: 2411-8.
17. Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brondum-Nielsen K, Gerdes AM, Moller P, Kristoffersson U, Olsson H, Borg A, Monteiro AN. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 2001; 10: 353-60.
18. Zhang X, Morera S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJ, Lindahl T, Freemont PS. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J 1998; 17: 6404-11.
19. Armakolas A, Ladopoulou A, Konstantopoulou I, Pararas B, Gomatos IP, Kataki A, Konstadoulakis MM, Stathopoulos GP, Markopoulos C, Leandros E, Gogas I, Yannoukakos D, Androulakis G. BRCA2 gene mutations in Greek patients with familial breast cancer. Hum Mutat 2002; 19: 81-2.
20. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001; 68: 700-10.
21. Williams RS, Green R, Glover JN. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat Struct Biol 2001; 8: 838-42.
22. Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure, Genes Dev 2002; 16: 583-93.